FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15858311000001106: Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
55794701000001117 Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58175401000001116 Rupafin 10mg tablets (GlaxoSmithKline UK Ltd) 30 tablet 2 x 15 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has specific active ingredient Rupatadine fumarate true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is a Rupatadine 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has AMP Rupafin 10mg tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has specific active ingredient Rupatadine fumarate false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rupatadine false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rupatadine false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has basis of strength substance Rupatadine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start